Literature DB >> 22402318

Pathogenesis and management of renovascular hypertension and ischemic nephropathy.

P Yerram1, P R Karuparthi, K Chaudhary.   

Abstract

Renovascular disease is an important cause of secondary hypertension and renal impairment. Atherosclerotic renal artery stenosis (ARAS) is the most important cause of renal artery stenosis (RAS), and has been linked to increased cardiovascular risk. The pathogenesis of renovascular hypertension is complex, but is mainly due to the over-activation of Renin-Angiotensin-Aldosterone system. A major consequence of untreated RAS is ischemic nephropathy, which is due to the sustained reduction in renal perfusion leading to derangement of microvascular function, and eventual development of interstitial fibrosis. Diagnosis of these conditions can be complex, sometimes needing invasive testing. Aggressive medical management is key to preventing progression of disease, as the role of revascularization in the management of ARAS is still not well defined.

Entities:  

Mesh:

Year:  2012        PMID: 22402318

Source DB:  PubMed          Journal:  Minerva Urol Nefrol        ISSN: 0393-2249            Impact factor:   3.720


  2 in total

1.  Renovascular hypertension treated by renal artery embolization.

Authors:  Jeong Ju Lee; Ki Soo Pai; Jae Il Shin; Se Jin Park
Journal:  Yonsei Med J       Date:  2014-01       Impact factor: 2.759

2.  Mesenchymal stem cells (MSC) prevented the progression of renovascular hypertension, improved renal function and architecture.

Authors:  Elizabeth B Oliveira-Sales; Edgar Maquigussa; Patricia Semedo; Luciana G Pereira; Vanessa M Ferreira; Niels O Câmara; Cassia T Bergamaschi; Ruy R Campos; Mirian A Boim
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.